Influenza Antiviral Drug Resistance, Questions & Answers (Updated on February 28 2014)
Q&A:
- What is
75 results in 0.0457 seconds.
-
Influenza Antiviral Drug Resistance, Questions & Answers (Updated on February 28 2014) (US CDC, edited)
[Source: US Centers for Disease Control and Prevention (CDC), full page: (LINK).]
Influenza Antiviral Drug Resistance, Questions & Answers (Updated on February 28 2014)
Q&A:
-
Expert Rev Anti Infect Ther. Emergence of a novel drug resistant H7N9 influenza virus: evidence based clinical potential of a natural IFN-α for infection control and treatment.
[Source: US National Library of Medicine, full page: (LINK). Abstract, edited.]
Expert Rev Anti Infect Ther. 2013 Dec 18. [Epub ahead of print]
Emergence of a novel drug resistant H7N9 influenza virus: evidence... -
Meeting of the WHO expert working group on surveillance of influenza antiviral susceptibility, Geneva, July 2013 (WHO, WER, November 1 2013, edited)
[Source: World Health Organization, Weekly Epidemiological Record, full PDF document: (LINK). Extract.]
Weekly epidemiological record / Relev? ?pid?miologique hebdomadaire, 1st NOVEMBER 2013, 88th year / No. 44-45, 2013, 88,... -
Jpn J Infect Dis. Virological Clearance Rate of High-Dose Oseltamivir or Triple-Combination Antiviral Therapy in Complicated 2009 Pandemic Influenza A (H1N1) Infection.
[Source: US National Library of Medicine, full page: (LINK). Abstract, edited.]
Jpn J Infect Dis. 2013;66(5):425-7.
Virological Clearance Rate of High-Dose Oseltamivir or Triple-Combination Antiviral Therapy in Complicated... -
Review of the 2012?2013 winter influenza season, northern hemisphere (WHO, May 31 2013)
[Source: World Health Organization, full PDF document: (LINK). Edited.]
Weekly epidemiological record / Relev? ?pid?miologique hebdomadaire
31 may 2013, 88th year / 31 mai 2013, 88e ann?e, No. 22, 2013, 88, 225?232... -
Antiviral Res. Antiviral resistance among highly pathogenic influenza A (H5N1) viruses isolated worldwide in 2002-2012 shows need for continued monitoring.
[Source: National Library of Medicine, full page: (LINK). Abstract, edited.]
Antiviral Res. 2013 Feb 28. pii: S0166-3542(13)00050-8. doi: 10.1016/j.antiviral.2013.02.013. [Epub ahead of print]...
Antiviral resistance among highly pathogenic -
PLoS ONE. Simultaneous Detection of Oseltamivir- and Amantadine-Resistant Influenza by Oligonucleotide Microarray Visualization
[Source: PLoS ONE, full text: (LINK). Abstract, edited.]
Simultaneous Detection of Oseltamivir- and Amantadine-Resistant Influenza by Oligonucleotide Microarray Visualization...
by Yingjie Zhang, Qiqi Liu, Dou Wang, Suhong Chen, Shengqi -
Proc Natl Acad Sci USA. Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus
[Source: Proceedings of the National Academy of Sciences of the United States of America, full page: (LINK). Abstract, edited.]
Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus...
-
Emerg Infect Dis. Microevolution of Highly Pathogenic Avian Influenza A(H5N1) Viruses Isolated from Humans, Egypt, 2007?2011
[Source: Emerging Infectious Diseases Journal, full text: (LINK). Edited.]
Research...
Microevolution of Highly Pathogenic Avian Influenza A(H5N1) Viruses Isolated from Humans, Egypt, 2007?2011
Mary Younan<SUP>1</SUP>, -
Giuseppe started a topic Review of the 2012 winter influenza season, southern hemisphere (WHO, November 2 2012): Variable activity seen with an increased but no exceptional mortalityin WHO (OMS)Review of the 2012 winter influenza season, southern hemisphere (WHO, November 2 2012): Variable activity seen with an increased but no exceptional mortality
[Source: World Health Organization, full PDF document: (LINK). Edited.]
Weekly epidemiological record / Relev? ?pid?miologique hebdomadaire
2 NOVEMBER 2012, 87th year / 2 NOVEMbre 2012, 87e ann?e / No. 44, 2012, 87,... -
Giuseppe started a topic Meetings of the WHO working group on surveillance of influenza antiviral susceptibility ? Geneva, November 2011 and June 2012 (Edited)in WHO (OMS)Meetings of the WHO working group on surveillance of influenza antiviral susceptibility ? Geneva, November 2011 and June 2012 (Edited)
[Source: World Health Organization, Weekly Epidemiological Record, full PDF document: (LINK). Edited.]
Weekly epidemiological record / Relev? ?pid?miologique hebdomadaire
28 september 2012, 87th year / 28 septembre 2012, 87e... -
Emerg Infect Dis. Spread of Influenza Virus A (H5N1) Clade 2.3.2.1 to Bulgaria in Common Buzzards
[Source: US Centers for Disease Control and Prevention, Emerging Infectious Diseases Journal, full text: (LINK). Edited.]
Volume 18, Number 10?October 2012...
Research
Spread of Influenza Virus A (H5N1) Clade 2.3.2.1 to -
Antiviral Res. Treatment of Oseltamivir-Resistant Influenza A (H1N1) Virus Infections in Mice With Antiviral Agents.
[Source: US National Library of Medicine, full text: (LINK). Abstract, edited.]
...
Antiviral Res. 2012 Jul 14. [Epub ahead of print]
Treatment of Oseltamivir-Resistant Influenza A (H1N1) Virus Infections in Mice With Antiviral Age -
PLoS ONE. Efficacy of Combined Therapy with Amantadine, Oseltamivir, and Ribavirin In Vivo against Susceptible and Amantadine-Resistant Influenza A Viruses
[Source: PLoS ONE, full text: (LINK). Abstract, edited.]
Efficacy of Combined Therapy with Amantadine, Oseltamivir, and Ribavirin In Vivo against Susceptible and Amantadine-Resistant Influenza A Viruses...
by Jack T. Nguyen, -
PLoS ONE. Triple Combination Antiviral Drug (TCAD) Composed of Amantadine, Oseltamivir, and Ribavirin Impedes the Selection of Drug-Resistant Influenza A Virus
[Source: PLoS ONE, full text: (LINK). Abstract, edited.]
Triple Combination Antiviral Drug (TCAD) Composed of Amantadine, Oseltamivir, and Ribavirin Impedes the Selection of Drug-Resistant Influenza A Virus...
by Justin D. Hoopes,